Skip to main content
TipRanks
Go Ultimate75% OFF

Meer Pieter Van-Der Insider Profile

4 Followers

Meer Pieter Van-Der, Ten Percent Owner at BG Medicine, holds 1.64M shares in BG Medicine (Ticker: BGMD). Most recently, Meer Pieter Van-Der Sold 200,000 shares of BG Medicine on Apr 19, 2012 for an estimated value of $1.32M.

Meer Pieter Van-Der's Trading History

BGMD
BG Medicine
Apr 19, 2012Ten Percent OwnerInformative Sell1.32M―
BGMD
Insider Shares: 1.64M (18.71%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Apr 19, 2012Informative Sell$1.32M200,000$6.60+70.40%
Feb 11, 2011Informative Buy$1.00M142,857$7.00+2.50%
Feb 11, 2011Informative Buy$1.06M1,738,735$0.60+2.50%

You May Also Like

Meer Pieter Van-Der insider profile FAQ

What is the percentage of profitable transactions made by Meer Pieter Van-Der?
The percentage of profitable transactions made by Meer Pieter Van-Der is 100%.
What is the average return per transaction made by Meer Pieter Van-Der?
The average return per transaction made by Meer Pieter Van-Der is 25.10%.
What stocks does Meer Pieter Van-Der hold?
Meer Pieter Van-Der holds: BGMD stocks.
What was Meer Pieter Van-Der’s latest transaction?
Meer Pieter Van-Der’s latest transaction was an Informative Sell of $1.32M.
What was Meer Pieter Van-Der's most profitable transaction?
Meer Pieter Van-Der’s most profitable transaction was an Informative Sell of BGMD stock on April 19, 2012. The return on the trade was 70.40%.
What is Meer Pieter Van-Der's role in BG Medicine?
Meer Pieter Van-Der's role in BG Medicine is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.